Application of Early Physical Therapy Regimens in Patients With Veno-venos Extracorporeal Membrane Oxygenation
VV-ECMO
1 other identifier
interventional
34
1 country
1
Brief Summary
Promote early recovery through the application of early physiotherapy programs for VV-ECMO patients
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2021
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2021
CompletedFirst Submitted
Initial submission to the registry
May 31, 2021
CompletedFirst Posted
Study publicly available on registry
June 8, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2022
CompletedJuly 15, 2021
May 1, 2021
1.7 years
May 31, 2021
July 13, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
VV-ECMO auxiliary time
the time for VV-ECMO auxiliary
1 year
Study Arms (2)
routine treatment
PLACEBO COMPARATORReview the collection of patient-related clinical data, collation of clinical data and outcome indicators
Experimental group
EXPERIMENTALImplement early physiotherapy programs. The early physiotherapy program for VV-ECMO patients mainly includes the establishment of multidisciplinary teams, safety assessment, early activity physiotherapy and respiratory physiotherapy.
Interventions
establishment of multidisciplinary teams, safety assessment, early activity physiotherapy and respiratory physiotherapy
Eligibility Criteria
You may qualify if:
- VV-ECMO assisted support
- lung failure (e.g. ARDS)
- age ≥18 years
- sober
- informed consent to this study
You may not qualify if:
- unstable blood flow mechanics
- active bleeding
- mental disorders that do not work together
- people waiting for lung transplants
- people at the end of life (e.g. advanced lung cancer)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
SAHZhejiangU
Hangzhou, Zhejiang, 310000, China
Study Officials
- STUDY CHAIR
Fei Zeng
Second Affiliated Hospital, School of Medicine, Zhejiang University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 31, 2021
First Posted
June 8, 2021
Study Start
January 1, 2021
Primary Completion
September 30, 2022
Study Completion
December 30, 2022
Last Updated
July 15, 2021
Record last verified: 2021-05
Data Sharing
- IPD Sharing
- Will not share